Herein, we focused on colon cancer to figure out the remedial impacts related to the secretome of MSCs (as a new strategy) through EGFR/c-Src/IRSp53/p-AKT/p-Stat3/cyclin D1 signaling pathway. This evidence concerns the gene SRC and colonic neoplasm.